Initial phase I data on tri-specific COVID-19 antiviral treatment ensovibep in healthy volunteers March 10, 2021
Ivermectin does not significantly improve the time to resolution of symptoms in mild COVID-19 March 9, 2021
Abivax stops phase IIb/III trial of ABX-464 in high-risk COVID-19 based on DSMB recommendation March 8, 2021
Innovation studies brilacidin in phase II trial for hospitalized patients with COVID-19 March 8, 2021
RSS